Parameter
| Biomarker | B2M | Full name | Beta-2 microglobulin | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Renal function assessment、Early warning of complications |
| Disease | Chronic Kidney Disease (CKD) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Blood, urine (protein detection) | ||
| Pathobiological Mechanisms | Mainly through glomerular filtration, elevated levels reflect impaired glomerular filtration function. | ||||
| Clinical Availability Status | Research verification stage | ||||
| Notes and Dynamics | It is related to the risk of end-stage renal disease ( ESRD ) and cardiovascular disease in CKD patients, and can improve the accuracy of risk prediction in patients with moderate CKD. | ||||